InsidersTradesSigma
인바디 Stock: price and directors' dealings · South Korea · DART (FSS)
Follow the 인바디 share price and the full management transaction log of the company, a listed issuer based in South Korea. Shares are quoted on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, 인바디 has recorded 33 insider filings. Market capitalisation: €664.4bn. The latest transaction was filed on 3 July 2026 (Purchase). Among the most active insiders: 차인준. Every trade is accessible without an account.
32
Insider Decl.
n/a
Thresholds
n/a
9 ops.
Buy Volume
n/a
2 ops.
Sell Volume
23Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 4,467 of 27,989 companies
69.4
score / 100
Value54
Quality84
FCF yld4.3%
Earn yld4.6%
EV/EBITDA14.1x
ROE·
Gross mgn77%
Net mgn13%
Debt/EBITDA0.2x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 3 July 2026
Declarations33 total
Other
Other(filed)
149,804 sharesKRXDART:20260428000253
25 of 33 declarations
About 인바디
InBody is a company specializing in the development of body composition measurement technologies. It is listed on the XKRX market.